Moving Medicine Forward
We work with experts across the industry to ensure our clinical trial design and execution is conducted with the utmost respect for patient safety and wellbeing.
We understand the decision to participate in any clinical research is not made lightly and are incredibly grateful to those patients and families who choose to do so. We are also thankful for the dedicated staff and clinicians at the hospitals and clinics that help conduct and support our research.
Current Trials
HOPE-3: Phase 3 Clinical Trial
A Study of deramiocel (CAP-1002) in Ambulatory and Non-Ambulatory Patients with Duchenne Muscular Dystrophy
Recruiting
Learn more about Capricor’s current ongoing Phase 3 clinical trial, HOPE-3. Search for study ID number: NCT05126758 at clinicaltrials.gov.
HOPE-2: Phase 2 Open Label Extension
Active, not recruiting
Search for study ID number: NCT04428476 at clinicaltrials.gov.
View Clinical Trial InfoEnrollment
For more information on enrollment in our current clinical trials, please contact us or visit clinicaltrials.gov.
Contact UsThe safety and efficacy of the investigational use of these products have not been determined. There is no guarantee that the investigational use listed will be filed with and/or approved for marketing by a regulatory agency.